IPO registrations (S-1, F-1) · Registrants
CapForce Inc.
- SEC CIK
- 1293818 · filings on EDGAR ↗
- Name on the registration
- OPGEN INC
- Former names
- OPGEN INC (2004–2026)
- Registration
- Form S-1, first filed 2015-03-03, last 2023-07-14; 8 initial registrations, 17 amendments
- Outcome
- Final prospectus filed 2015-05-05; declared effective 2015-05-04; withdrawal requested 2023-09-28
- Industry (SIC)
- Services-Management Consulting Services 8742
- Incorporated in
- DE
- Business address
- UNIT L33A-7, TOWER A, MENARA UOA BANGSAR, NO. 5, JALAN BANGSAR UTAMA 1, Kuala Lumpur 59000
- EIN
- 06-1614015
- Ticker
- CFOR (OTC)
- EDGAR entity type
- operating
- Insiders and CEO pay
- CapForce Inc. on the corporate pages
Offering terms
- Proposed price range
- $5.50–$6.50 per share (S-1/A filed 2015-04-28)
- Final price
- $6.00 per share, within the range (424B4 filed 2015-05-05, an initial public offering)
- Shares sold
- 2,500,000
- Gross proceeds
- $15,000,000 before underwriting discounts and any over-allotment option
- Listing
- Nasdaq under the symbol OPGN
- Lead underwriters
- Maxim Group
- Syndicate
- National Securities Corporation
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Business registration: OPGEN, INC. EXACT (EIN (EXACT, as the state registration reports it))
- Form 5500 plan sponsor: OPGEN INC. EXACT (EIN (EXACT))
- Form D issuer: OPGEN INC EXACT (CIK (EXACT))
- SEC filer: CapForce Inc. EXACT (CIK (EXACT))
- Person page: R Don Elsey Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director))
- Person page: Timothy C Dec Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Officer))
Filings 51
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2015-03-03 | S-1 | S-1 (registration) | OPGEN INC | 0001079973-15-000157 ↗ |
| 2015-03-20 | S-1/A | S-1/A (amendment) | OPGEN INC | 0001079973-15-000212 ↗ |
| 2015-04-06 | S-1/A | S-1/A (amendment) | OPGEN INC | 0001047469-15-003200 ↗ |
| 2015-04-14 | S-1/A | S-1/A (amendment) | OPGEN INC | 0001047469-15-003470 ↗ |
| 2015-04-17 | S-1/A | S-1/A (amendment) | OPGEN INC | 0001047469-15-003614 ↗ |
| 2015-04-23 | S-1/A | S-1/A (amendment) | OPGEN INC | 0001047469-15-003845 ↗ |
| 2015-04-28 | S-1/A | S-1/A (amendment) | OPGEN INC | 0001047469-15-004058 ↗ |
| 2015-04-30 | S-1/A | S-1/A (amendment) | OPGEN INC | 0001047469-15-004178 ↗ |
| 2015-05-01 | S-1/A | S-1/A (amendment) | OPGEN INC | 0001047469-15-004265 ↗ |
| 2015-05-04 | EFFECT | EFFECT (declared effective) | OPGEN INC | 9999999995-15-001208 ↗ |
| 2015-05-05 | 424B4 | 424B4 (final prospectus) | OPGEN INC | 0001047469-15-004386 ↗ |
| 2016-07-20 | EFFECT | EFFECT (declared effective) | OPGEN INC | 9999999995-16-005199 ↗ |
| 2016-09-09 | EFFECT | EFFECT (declared effective) | OPGEN INC | 9999999995-16-005660 ↗ |
| 2017-06-01 | S-1 | S-1 (registration) | OPGEN INC | 0001079973-17-000319 ↗ |
| 2017-06-29 | S-1/A | S-1/A (amendment) | OPGEN INC | 0001079973-17-000368 ↗ |
| 2017-07-11 | S-1/A | S-1/A (amendment) | OPGEN INC | 0001079973-17-000389 ↗ |
| 2017-07-12 | EFFECT | EFFECT (declared effective) | OPGEN INC | 9999999995-17-001793 ↗ |
| 2017-07-14 | 424B4 | 424B4 (final prospectus) | OPGEN INC | 0001079973-17-000405 ↗ |
| 2017-12-18 | S-1 | S-1 (registration) | OPGEN INC | 0001079973-17-000743 ↗ |
| 2018-01-31 | S-1/A | S-1/A (amendment) | OPGEN INC | 0001079973-18-000056 ↗ |
| 2018-02-01 | S-1MEF | S-1MEF (added securities) | OPGEN INC | 0001079973-18-000064 ↗ |
| 2018-02-01 | EFFECT | EFFECT (declared effective) | OPGEN INC | 9999999995-18-000307 ↗ |
| 2018-02-05 | 424B4 | 424B4 (final prospectus) | OPGEN INC | 0001079973-18-000087 ↗ |
| 2018-04-12 | EFFECT | EFFECT (declared effective) | OPGEN INC | 9999999995-18-000809 ↗ |
| 2018-04-12 | EFFECT | EFFECT (declared effective) | OPGEN INC | 9999999995-18-000811 ↗ |
| 2019-03-01 | S-1 | S-1 (registration) | OPGEN INC | 0001079973-19-000111 ↗ |
| 2019-03-13 | S-1/A | S-1/A (amendment) | OPGEN INC | 0001079973-19-000135 ↗ |
| 2019-03-21 | EFFECT | EFFECT (declared effective) | OPGEN INC | 9999999995-19-000483 ↗ |
| 2019-03-21 | EFFECT | EFFECT (declared effective) | OPGEN INC | 9999999995-19-000484 ↗ |
| 2019-03-25 | EFFECT | EFFECT (declared effective) | OPGEN INC | 9999999995-19-000516 ↗ |
| 2019-09-16 | S-1 | S-1 (registration) | OPGEN INC | 0001553350-19-000952 ↗ |
| 2019-10-15 | S-1/A | S-1/A (amendment) | OPGEN INC | 0001079973-19-000512 ↗ |
| 2019-10-17 | S-1/A | S-1/A (amendment) | OPGEN INC | 0001079973-19-000524 ↗ |
| 2019-10-23 | EFFECT | EFFECT (declared effective) | OPGEN INC | 9999999995-19-002371 ↗ |
| 2019-10-25 | 424B4 | 424B4 (final prospectus) | OPGEN INC | 0001079973-19-000538 ↗ |
| 2020-01-23 | EFFECT | EFFECT (declared effective) | OPGEN INC | 9999999995-20-000140 ↗ |
| 2020-02-07 | EFFECT | EFFECT (declared effective) | OPGEN INC | 9999999995-20-000294 ↗ |
| 2020-06-29 | EFFECT | EFFECT (declared effective) | OPGEN INC | 9999999995-20-001695 ↗ |
| 2020-12-04 | EFFECT | EFFECT (declared effective) | OPGEN INC | 9999999995-20-003416 ↗ |
| 2021-06-11 | EFFECT | EFFECT (declared effective) | OPGEN INC | 9999999995-21-002318 ↗ |
| 2021-08-19 | EFFECT | EFFECT (declared effective) | OPGEN INC | 9999999995-21-003253 ↗ |
| 2022-12-01 | S-1 | S-1 (registration) | OPGEN INC | 0001079973-22-001490 ↗ |
| 2022-12-30 | S-1/A | S-1/A (amendment) | OPGEN INC | 0001079973-22-001583 ↗ |
| 2023-01-05 | S-1/A | S-1/A (amendment) | OPGEN INC | 0001079973-23-000021 ↗ |
| 2023-01-06 | EFFECT | EFFECT (declared effective) | OPGEN INC | 9999999995-23-000050 ↗ |
| 2023-04-07 | S-1 | S-1 (registration) | OPGEN INC | 0001079973-23-000458 ↗ |
| 2023-04-27 | S-1/A | S-1/A (amendment) | OPGEN INC | 0001079973-23-000559 ↗ |
| 2023-05-01 | EFFECT | EFFECT (declared effective) | OPGEN INC | 9999999995-23-001207 ↗ |
| 2023-07-14 | S-1 | S-1 (registration) | OPGEN INC | 0001079973-23-000959 ↗ |
| 2023-09-28 | RW | RW (withdrawal request) | OPGEN INC | 0001079973-23-001332 ↗ |
| 2023-11-22 | EFFECT | EFFECT (declared effective) | OPGEN INC | 9999999995-23-003423 ↗ |
Prospectus pages read 4
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2015-04-28 | S-1/A | registration statement | $5.50–$6.50 | $6.00 | 2,500,000 | $15,000,000 | 2 | primary document; range, price sentence, shares headline, proceeds computed, cover names 2 | document ↗ | |
| 2015-04-30 | S-1/A | registration statement | - | - | 0 | primary document; no terms found | document ↗ | |||
| 2015-05-01 | S-1/A | registration statement | - | - | 0 | primary document; no terms found | document ↗ | |||
| 2015-05-05 | 424B4 | final prospectus | $6.00 | 2,500,000 | $15,000,000 | Nasdaq OPGN | 2 | primary document; price sentence, shares headline, proceeds computed, cover names 2 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| ATWOOD BRIAN G | Director; Director,TenPercentOwner | 3 | 2015–2016 | ||
| DEC TIMOTHY C | Officer | Cheif Financial Officer; Chief Financial Officer | 19 | 2015–2021 | person page Fuzzy |
| HARRIS & HARRIS GROUP INC /NY/ | TenPercentOwner | 2 | 2015 | ||
| Harris Timothy J.R. | Director | 8 | 2015–2018 | ||
| Howe Timothy | Director | 2 | 2015 | ||
| JONES EVAN/ FA | Director; Director,Officer; Director,Officer,TenPercentOwner; Officer | Chief Executive Officer | 22 | 2015–2021 | |
| jVen Capital, LLC | Director,Officer,TenPercentOwner; TenPercentOwner | Chairman and CEO | 9 | 2015–2017 | |
| KRENITSKY KEVIN | Officer | President | 6 | 2015–2016 | |
| McCarthy Laurence | Director | 3 | 2015–2016 | ||
| Ushio Misti | Director | 7 | 2015–2019 | ||
| Versant Side Fund III, L.P. | TenPercentOwner | 2 | 2015 | ||
| Versant Venture Capital III, L.P. | TenPercentOwner | 2 | 2015 | ||
| Versant Ventures III, LLC | TenPercentOwner | 2 | 2015 | ||
| Rubin David | Director | 1 | 2015 | ||
| Merck & Co., Inc. | TenPercentOwner | 4 | 2015–2018 | ||
| Merck Global Health Innovation Fund, LLC | TenPercentOwner | 4 | 2015–2018 | ||
| Merck Sharp & Dohme Corp. | TenPercentOwner | 4 | 2015–2018 | ||
| D'Andrea Harry J | Director | 6 | 2016–2018 | ||
| Nova Tina Susan | Director | 5 | 2017–2019 | ||
| Sapiro Vadim M. | Officer | Chief Information Officer | 4 | 2017–2019 | |
| Elsey R Don | Director | 6 | 2019–2023 | person page Fuzzy | |
| Bacher Johannes | Officer | Chief Operating Officer | 11 | 2020–2023 | |
| Crovetto Mario | Director | 5 | 2020–2023 | ||
| Fernandes Prabhavathi | Director | 5 | 2020–2023 | ||
| Rhodes William E. | Director | 5 | 2020–2023 | ||
| Schacht Oliver | Director,Officer | Chief Executive Officer | 10 | 2020–2023 | |
| Curetis N.V. in Liquidation | TenPercentOwner | 4 | 2020 | ||
| Weber Albert | Officer | Chief Finanical Officer | 3 | 2022–2023 | |
| Schlaeppi Yvonne | Director | 3 | 2022–2023 | ||
| Ben-Tzvi Avraham | Director | 2 | 2024 | ||
| Lazar David E. | Director,Officer,TenPercentOwner | Chief Executive Officer | 7 | 2024 | |
| McMurdo Matthew Charles | Director | 2 | 2024 | ||
| NATAN DAVID | Director | 2 | 2024 | ||
| AEI Capital Ltd | TenPercentOwner | 4 | 2024–2025 | ||
| Azudin Mohd Azham | Officer | COO | 3 | 2024–2026 | |
| Bonte Christian-Laurent | Director; Officer | Chief Executive Officer | 3 | 2024–2025 | |
| Chua Kok Hoe Victor | Director | 3 | 2024–2026 | ||
| Lim Zhao Qi Ken | Director | 3 | 2024–2026 | ||
| Low Yu Jie Ethan | Director | 3 | 2024–2026 | ||
| Wong Poh Yin Constance | Director | 3 | 2024–2026 | ||
| Yee Gillian Tan Rou | Officer | Corporate Secretary | 3 | 2024–2026 | |
| Syed Mohd Syed Johan Bin | Officer | Chief Technology Officer; Chief Technology Officer (CTO) | 2 | 2025 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Private offerings before or after (Form D)
| First filed | Issuer | Industry | Offering | Sold | Investors | Filings |
|---|---|---|---|---|---|---|
| 2022-10-12 | OPGEN INC | Biotechnology | $3,381,338 | $3,381,338 | 1 | 1 |
| 2021-02-24 | OPGEN INC | Biotechnology | $25,000,000 | $25,000,000 | 1 | 1 |
| 2020-12-04 | OPGEN INC | Biotechnology | $10,000,000 | $9,974,027 | 1 | 1 |
| 2018-08-03 | OPGEN INC | Biotechnology | $285,512 | $285,512 | 1 | 1 |
| 2017-09-21 | OPGEN INC | Biotechnology | $110,000 | $110,000 | 1 | 1 |
| 2017-06-20 | OPGEN INC | Biotechnology | $1,500,000 | $500,000 | 2 | 1 |
| 2016-05-27 | OPGEN INC | Biotechnology | $10,355,005 | $7,227,504 | 10 | 1 |
| 2015-07-23 | OPGEN INC | Biotechnology | $2,584,090 | $2,584,090 | 4 | 1 |
| 2015-02-23 | OPGEN INC | Biotechnology | $1,500,000 | $1,243,999 | 9 | 1 |
| 2014-07-17 | OPGEN INC | Biotechnology | $1,500,000 | $1,079,917 | 4 | 1 |
| 2014-04-04 | OPGEN INC | Biotechnology | $4,000,000 | $3,999,864 | 29 | 1 |
| 2012-03-14 | OPGEN INC | Biotechnology | $17,000,000 | $6,100,000 | 28 | 1 |
| 2012-02-16 | OPGEN INC | Biotechnology | $3,699,209 | $3,532,442 | 27 | 1 |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Business registration | OPGEN, INC. | MD | State business registries | EIN (EXACT, as the state registration reports it) |
| Form D issuer | OPGEN INC | MD | Form D private offerings | CIK (EXACT) |
| SEC filer | CapForce Inc. | SEC filers (EDGAR) | CIK (EXACT) | |
| Form 5500 plan sponsor | OPGEN INC. | EIN (EXACT) | ||
| Person page | R Don Elsey | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director) | |
| Person page | Timothy C Dec | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Officer) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.